Virility Medical

Company Overview

Snapshot

Founded in May 2016 by Tal Gollan, Virility Medical operates with 1-10 employees. The company has raised $21 million across 8 funding rounds from 7 investors, with Migdal Insurance and Financial Holdings leading one of its May 2024 rounds. In May 2024, Virility Medical launched its in2 device for premature ejaculation treatment in Israel, following its successful release in the UK.

Business overview

Virility Medical is a consumer healthcare company focused on sexual health, developing a state-of-the-art, FDA-cleared wearable device for men and women. Its core product is the world's first clinically proven wearable device that uses muscle stimulation to delay ejaculation by enhancing the ability to contract pelvic-floor muscles. The company operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving patients globally.

Strategic signal

In May 2024, Virility Medical launched its in2 device in Israel, a significant market expansion following its successful UK release. This launch, coupled with regulatory approvals from the FDA and CE, signals strong commercial momentum and validates the company's technology in the global sexual health market, indicating a transition from product development to widespread market penetration.

Company Intelligence Q&A

What is Virility Medical's primary product?

Virility Medical has developed the in2 device, a clinically proven wearable device based on muscle stimulation designed to delay ejaculation by enhancing men's ability to contract pelvic-floor muscles.

When did Virility Medical launch its in2 device in Israel?

In May 2024, Virility Medical launched its in2 device for the treatment of premature ejaculation in Israel, following a successful release in the UK.

Who was appointed as CEO of Virility Medical?

Sharon Ravid took over as CEO of Virility Medical in October 2023, leading the company's transition from product development to the commercial stage.

Which investors participated in Virility Medical's July 2022 funding round?

In July 2022, Virility Medical received funding from Migdal Insurance and Financial Holdings and Arkin Tech.

Has Virility Medical received regulatory approvals for its device?

Yes, the in2 device has received regulatory approvals, including FDA clearance for marketing in the US, CE approval for Europe, and approval from the Israeli Ministry of Health.